- The
first medical cannabis incubator and accelerator financing medical
cannabis, CBD and hemp companies through a debt facility
- Well-positioned
to gain market share in the emerging cannabis market
- Global
legal marijuana market projected to be $146.4 billion by 2025
- Pursuing
opportunities in emerging markets and the unique market conditions in the
cannabis industry enable unique growth for the company
- Robust
loan portfolio consisting of diverse, successful players in the cannabis
industry
- Actively
looking beyond borders and creating global companies with strong
fundamentals that are ready for expansion
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt:
O3X4) is a merchant bank focused on providing debt and equity funding in the
mid to late stages of a target company’s development and for technologies that
are developed and validated by revenues. Redfund’s current focus is on medical
cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.
As the first medical cannabis incubator and accelerator
financing medical cannabis, CBD and hemp companies through a debt facility,
Redfund is effectively bridging finance gaps and helping revenue-producing
medical cannabis-related companies grow and build their valuations without
prematurely diluting their equity.
The central components of the company’s business strategy
are:
- Establishing
the foundation of a loan portfolio that generates revenues through monthly
interest income from loans to cover all general and administrative
expenses related to day-to-day operations.
- Growing
shareholder value by converting all or part of loans and warrants into
equity in portfolio clients as clients build their valuations by entering
the public markets or becoming the high-priced targets of larger entities.
Redfund was designed by bankers and entrepreneurs possessing
years of experience in business, consulting, capital markets, corporate finance
and healthcare services. The company is actively looking beyond borders and
creating global companies that have strong fundamentals and are ready to
expand.
Redfund’s investments are deployed to companies that have demonstrated
success in their business but need a capital bridge in order to expand.
Redfund’s team of professionals vet every project and analyzes each prospective
client’s financials and business plans. Once a project is approved, Redfund’s
legal team carefully scrutinizes the collateral used to securitize the
individual loans.
The strategy employed by Redfund includes:
- Diversifying
investments in Canada and other countries
- Building
an international footprint with established national leaders
- Funding
new drug delivery systems and helping nutraceuticals become mainstream
drugs
- Introducing
companies to Canada as a viable option for public listings
- Becoming
a premier go-to lender for established companies
The company’s revenue sources include:
- Interest-bearing
debt instruments with asset-backed collateral to securitize loans
- Equity
kicker of warrants coverage on original loan
- Conversion
ability of loan in its entirety
- Advisory
fees from contracts for consulting on growth strategies
- Right
of first refusal on future financing in each company funded
For more information, visit the company’s website at www.RedfundCapital.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment